52.81 -3.10 (-5.62%)
AMAG
Stock Details
Last Trade:52.81 Change:-3.10 (-5.62%) Prev Close:55.91 Open: 55.20 Days Range:52.59 – 55.49 52 Week Range: 18.33 - 58.23 Volume:869336 P/E: N/AEPS:-5.22
View AllRecent Alerts 07/04/09
Recent Alert on 07/01/09 at 9:30am
OSK, BORL, PARD, AMAG, LNN See Volume and Upside Price Action
OSK, BORL, PARD, AMAG, LNN See Volume and Upside Price Action
Oshkosh Corporation (NYSE: OSK) +29%, Borland (Nasdaq: BORL) +17%, Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) +12%, AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) +5.6%, Lindsay Corporation (NYSE: LNN) +8% are all seeing significant volume and upside... Read More
Recent Alert on 06/30/09 at 5:14pm
After-Hours Movers 6/30: OSK, SNX Higher; FRPT, MYGN, ZZ, SQNM Lower
After-Hours Movers 6/30: OSK, SNX Higher; FRPT, MYGN, ZZ, SQNM Lower
Recent Alert on 06/30/09 at 7:43am
AMAG Pharma (AMAG) Expects FDA Action Letter for Feraheme(TM) Injection Within Next Few Days
AMAG Pharma (AMAG) Expects FDA Action Letter for Feraheme(TM) Injection Within Next Few Days
Recent Alert on 06/30/09 at 7:43am
AMAG Pharma (AMAG) Expects FDA Action Letter for Feraheme(TM) Injection Within Next Few Days
AMAG Pharma (AMAG) Expects FDA Action Letter for Feraheme(TM) Injection Within Next Few Days
View AllRecent Press Releases
Press Release on 06/30/09 at 4:44pm
FDA Approves Feraheme(TM) to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
FDA Approves Feraheme(TM) to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 07/01/09 at 4:48am
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
Blog Posts on 06/28/09 at 5:32am
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart